Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Yeonhee Park (Daejeon, Republic of Korea), Yeonhee Park, Myoung-Rin Park, Dong-Il Park, Chae-Uk Chung, Jae-Young Moon, Jeong-Eun Lee, Hee-sun Park, Sung-su Jung, Sun-young Kim, Ju-Ock Kim. Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy. Eur Respir J 2016; 48: Suppl. 60, 4838

Member's Comments

No comment yet.

Related content which might interest you: Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 A case series of eight patients treated with alectinib including a case of interstitial lung disease Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Interstitial lung diseases and lung cancer Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Evaluation of lung cancer patients with distant organ metastasis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Differentiating incidental lung nodules due to lung cancer from those due to coccidioidomycosis Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Pleuroparenchymal fibroelastosis (PPFE) – Resembling features in patients with malignancies Source: International Congress 2015 – IIPs: orphan Year: 2015 Neoplasia in patients with ILD; shortened survival Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer Source: International Congress 2016 – IPF pathogenesis Year: 2016 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014